HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Garrett SchmittNo CommentsCMMI, drug prices, HHS, Pharmaceuticals

The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices. The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms…

Recent Posts

  • RECORDED WEBINAR: Driving Shared Savings Through Regional Efficiency: Unlocking the MSSP ACO Benchmark with Wakely
  • CMS announces new value based payment model for technology-enabled care
  • RECORDED WEBINAR: How AI Agents Can Power the Modern Value Based Team
  • Maturing in Risk: Unlocking Value Through MSSP Participation
  • RECORDED WEBINAR: How Houston Methodist ACO is cracking the code on HCCs
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us